1. Home
  2. TTRX vs PLAY Comparison

TTRX vs PLAY Comparison

Compare TTRX & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$10.09

Market Cap

298.8M

Sector

Health Care

ML Signal

N/A

Logo Dave & Buster's Entertainment Inc.

PLAY

Dave & Buster's Entertainment Inc.

N/A

Current Price

$8.57

Market Cap

357.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
TTRX
PLAY
Founded
2015
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
298.8M
357.3M
IPO Year
2025
2011

Fundamental Metrics

Financial Performance
Metric
TTRX
PLAY
Price
$10.09
$8.57
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
★ $25.00
$13.00
AVG Volume (30 Days)
83.7K
★ 1.8M
Earning Date
11-25-2026
12-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$900.00
$3.11
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.57
$6.26
52 Week High
$16.45
$22.10

Technical Indicators

Market Signals
Indicator
TTRX
PLAY
Relative Strength Index (RSI) 42.31 61.22
Support Level $10.05 $6.50
Resistance Level $10.72 $8.62
Average True Range (ATR) 0.78 0.56
MACD -0.02 0.15
Stochastic Oscillator 29.98 93.14

Price Performance

Historical Comparison
TTRX
PLAY

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

About PLAY Dave & Buster's Entertainment Inc.

Dave & Buster's Entertainment Inc is an owner and operator of entertainment and dining venues in North America that offer experiences for both adults and families under the Dave & Buster's and Main Event brands. The company combines various forms of entertainment, including games, bowling, and watching live sports and other televised events, with a full menu of entrees and appetizers and a selection of alcoholic and non alcoholic beverages, all in one location. Its concept focuses on providing customers the opportunity to Eat, Drink, Play, and Watch, appealing to a balanced mix of adults, families, and teenagers. The company also operates internationally in the early stage as a franchisor of the Dave & Buster's brand.

Share on Social Networks: